An ESR study of the nitroxide radical of pentastarch-conjugated deferoxamine
- 10 January 1990
- journal article
- research article
- Published by Elsevier in Free Radical Biology & Medicine
- Vol. 9 (3) , 211-218
- https://doi.org/10.1016/0891-5849(90)90030-m
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Protection against tissue damage in vivo by desferrioxamine: What is its mechanism of action?Free Radical Biology & Medicine, 1989
- Stimulation and inhibition of iron-dependent lipid peroxidation by desferrioxamineBiochemical and Biophysical Research Communications, 1988
- Visual and Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine InfusionsNew England Journal of Medicine, 1986
- ACUTE DEAFNESS AND DESFERRIOXAMINEThe Lancet, 1985
- Ocular changes in patients undergoing long-term desferrioxamine treatment.British Journal of Ophthalmology, 1984
- Acute Iron PoisoningAmerican Journal of Diseases of Children, 1980
- Inhibition of the iron-catalysed formation of hydroxyl radicals from superoxide and of lipid peroxidation by desferrioxamineBiochemical Journal, 1979
- Iron chelation therapy with deferoxamine in Cooley anemiaThe Journal of Pediatrics, 1978
- Continuous Subcutaneous Administration of Deferoxamine in Patients with Iron OverloadNew England Journal of Medicine, 1977
- Deferoxamine as a Chelating AgentClinical Toxicology, 1971